QSS
RVNC

Quantitative Systematic Strategies’s Revance Therapeutics, Inc. RVNC Stock Holding History

Quantitative Systematic Strategies’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-15,850
Closed -$311K – 624
2015
Q1 		$311K Buy
+15,850
New +$274K 0.09% 338

Other funds holding RVNC

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
NHG
NQ HCIF GP Raleigh, North Carolina $50.2M AUM 45.53% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Quantitative Systematic Strategies's RVNC Position: Q2 2015 in Review

Quantitative Systematic Strategies sold out of Revance Therapeutics, Inc. (RVNC) in Q2 2015, closing a stake of 15,850 shares — an estimated $311K sold.

Quantitative Systematic Strategies first reported a position in RVNC in Q1 2015 and held it in 1 quarter. The position peaked at $311K in Q1 2015. 88 funds tracked by Wall St. Rank hold RVNC as of Q2 2015.

  • Quantitative Systematic Strategies reported no remaining Revance Therapeutics, Inc. position as of Q2 2015 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 15,850 Revance Therapeutics, Inc. shares in Q2 2015, an estimated $311K.
  • Quantitative Systematic Strategies first reported a position in Revance Therapeutics, Inc. in Q1 2015 and held it in 1 quarter.
  • Quantitative Systematic Strategies's Revance Therapeutics, Inc. position peaked at $311K in Q1 2015.
  • 88 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q2 2015.

Based on Quantitative Systematic Strategies's 13F filing for Q2 2015, filed 9 Jul 2015.